{"schema_version":"secwatch.filing_event.v1","accession":"0001013762-23-003854","form_type":"8-K","ticker":"FRMM","cik":"0001690080","company_name":"FORUM MARKETS Inc","filed_at":"2023-10-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:30.068688+00:00","generated_at":"2026-06-10T00:04:21.254777+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"180 Life Sciences receives Nasdaq non-compliance notice over shareholder approval for offering","bullets":["Received Nasdaq notice on Oct 11, 2023 for violating Listing Rule 5635(d) requiring shareholder approval.","Offering involved 666,925 shares at $0.65, pre-funded warrants for 3.95M shares at $0.6499, and 4.62M common warrants.","Nasdaq ruled that the best-efforts offering with one investor buying 98% was not a public offering.","No immediate impact on listing; Company has 45 days to submit a plan, with possible 180-day extension.","Company intends to submit a compliance plan but cannot guarantee acceptance or regaining compliance."],"urls":{"canonical":"https://secwatch.observer/filing/0001013762-23-003854","json":"https://secwatch.observer/filing/0001013762-23-003854.json","markdown":"https://secwatch.observer/filing/0001013762-23-003854.md","text":"https://secwatch.observer/filing/0001013762-23-003854.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1690080/000101376223003854/0001013762-23-003854-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1690080/000101376223003854/ea186707-8k_180life.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T00:04:21.254777+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"89c3553936da54ebfa9dca3d4d37eb4661f13f64","claim":"FORUM MARKETS Inc received a nasdaq deficiency notice notice regarding other (rules 5635(d)).","evidence_excerpt":"of Nasdaq’s shareholder approval rules due to the type of offering, a best efforts offering pursuant to a placement agency agreement, and the fact that one investor purchased 98% of the Offering. As a result, because the Offering represented greater than 20% of the Common Stock outstanding and was priced below the Minimum Price, the Staff determined that","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1690080/000101376223003854/0001013762-23-003854-index.htm","confidence":0.95,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nasdaq"},{"label":"Notice","value":"deficiency notice"},{"label":"Rules","value":"5635(d)"}],"fact_type":"exchange_compliance_notice"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}